Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 50090-1669

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 50090-1669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B5387e98-figure-01 (B5387e98 Figure 01)

FDA Label Image

B5387e98-figure-02 (B5387e98 Figure 02)

FDA Label Image

B5387e98-figure-03 (B5387e98 Figure 03)

This appears to be a medication description for a combination of Albuterol and Ipratropium called "Mimutoral Sulfote Inhalation Solution". The dosage and instructions for use are not provided in the given text.*

FDA Label Image

B5387e98-figure-04 (B5387e98 Figure 04)

This document outlines the adverse events that occurred in greater than 1% of at least one treatment group and where the combination treatment showed the highest percentage. The adverse events were experienced by patients across three different treatments: Albuterol, Ipratropium, and Ipratropium Bromide. The COSTART terms were used to categorize the adverse events.*

FDA Label Image

B5387e98-figure-05 (B5387e98 Figure 05)

FDA Label Image

B5387e98-figure-06 (B5387e98 Figure 06)

FDA Label Image

B5387e98-figure-07 (B5387e98 Figure 07)

FDA Label Image

B5387e98-figure-08 (B5387e98 Figure 08)

FDA Label Image

Label Image (Lbl500901669)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.